These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1448490)

  • 1. The CCK-A receptor antagonist, devazepide, blocks the anorectic action of CCK but not peripheral serotonin in rats.
    Eberle-Wang K; Simansky KJ
    Pharmacol Biochem Behav; 1992 Nov; 43(3):943-7. PubMed ID: 1448490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329.
    Cooper SJ; Dourish CT; Barber DJ
    Br J Pharmacol; 1990 Jan; 99(1):65-70. PubMed ID: 2331576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
    Corp ES; Curcio M; Gibbs J; Smith GP
    Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats.
    Melville LD; Smith GP; Gibbs J
    Pharmacol Biochem Behav; 1992 Nov; 43(3):975-7. PubMed ID: 1448494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCK(A) and 5-HT3 receptors interact in anorectic responses to amino acid deficiency.
    Aja SM; Barrett JA; Gietzen DW
    Pharmacol Biochem Behav; 1999 Mar; 62(3):487-91. PubMed ID: 10080241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Devazepide attenuates dl-fenfluramine-induced suppression of gastric emptying but not food intake in the 17 h food-deprived rat.
    Francis J; Dourish CT; Cooper SJ
    Physiol Behav; 1997 Sep; 62(3):545-50. PubMed ID: 9272662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin contracts the isolated rat pylorus via a 5-HT2-like receptor.
    Eberle-Wang K; Braun BT; Simansky KJ
    Am J Physiol; 1994 Jan; 266(1 Pt 2):R284-91. PubMed ID: 8304552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin- and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain.
    Li BH; Rowland NE
    Regul Pept; 1994 Mar; 50(3):223-33. PubMed ID: 8016407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent effects of CCK and devazepide in male and female rats.
    Salorio CF; Hammond PB; Schwartz GJ; McHugh PR; Moran TH
    Physiol Behav; 1994 Oct; 56(4):645-8. PubMed ID: 7800726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
    Verbaeys I; León-Tamariz F; Buyse J; De Cuyper M; Pottel H; Van Boven M; Cokelaere M
    Br J Pharmacol; 2007 Oct; 152(3):396-403. PubMed ID: 17618299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats.
    Grignaschi G; Mantelli B; Fracasso C; Anelli M; Caccia S; Samanin R
    Br J Pharmacol; 1993 Jun; 109(2):491-4. PubMed ID: 8358548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of central and peripheral anorectic effects of caerulein by L-364,718.
    Leighton GE; Griesbacher T; Hill RG; Hughes J
    Eur J Pharmacol; 1989 Feb; 161(2-3):255-8. PubMed ID: 2721558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
    Ebenezer IS; Baldwin BA
    Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of BIM-18216, a novel cholecystokinin receptor antagonist, on food intake reduction induced by cholecystokinin.
    Laferrere B; Nguyen M; Bonhomme G; Legall A; Basdevant A; Guy-Grand B
    Behav Neurosci; 1991 Oct; 105(5):707-11. PubMed ID: 1815620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cholecystokinin in the anorexia produced by duodenal delivery of glucose in rats.
    Woltman T; Reidelberger R
    Am J Physiol; 1996 Dec; 271(6 Pt 2):R1521-8. PubMed ID: 8997348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Devazepide reverses the anorexic effect of simmondsin in the rat.
    Cokelaere MM; Busselen P; Flo G; Daenens P; Decuypere E; Kühn E; Van Boven M
    J Endocrinol; 1995 Dec; 147(3):473-7. PubMed ID: 8543917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous infusion of CCKA-receptor antagonist increases food intake in rats.
    Miesner J; Smith GP; Gibbs J; Tyrka A
    Am J Physiol; 1992 Feb; 262(2 Pt 2):R216-9. PubMed ID: 1539728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of interaction between devazepide and 8-OH-DPAT-induced hyperphagia in the rat.
    Francis J; Dourish CT; Cooper SJ
    Physiol Behav; 1996 Nov; 60(5):1337-40. PubMed ID: 8916191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.